Transition modeling of neuropsychiatric impairment in HIV
详细信息    查看全文
文摘

A continuous time Markov model adequately described efavirenz treatment-associated neuropsychiatric impairment.

Efavirenz dose reduction from 600 to 400 mg would reduce the duration of neuropsychiatric impairment in HIV patients who get impaired without affecting efficacy.

Delayed neuropsychiatric symptoms are less likely related to efavirenz exposure.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700